Advanced search
Publication Cover
Postgraduate Medicine Volume 122, 2010 - Issue 5
Submit an article Journal homepage
26
Views
3
CrossRef citations to date
0
Altmetric
Practice Pearl

Review of Liraglutide versus Sitagliptin for Patients with Uncontrolled Type 2 Diabetes: More Effective HbA1c Reduction with Subcutaneous GLP-1 Receptor Agonist Versus an Oral DPP-4 Inhibitor

Daniel A. Nadeau HealthReach Diabetes Endocrine Nutrition Center, Hampton, NHCorrespondence[email protected]
, MD
Pages 185-188 | Published online: 13 Mar 2015
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Practice Pearl

Liraglutide showed greater efficacy than sitagliptin in reducing HbA1c and facilitating weight loss in patients with uncontrolled type 2 diabetes.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.